Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitoferrin-1 (encoded by the SLC25A37 gene) is a mitochondrial inner membrane transporter essential for importing ferrous iron (Fe2+) into the mitochondrial matrix, where this iron is required for the biosynthesis of heme and iron–sulfur (Fe-S) clusters[1][2][3]. Mitoferrin-1 is especially important in developing erythroid cells, where demand for mitochondrial iron is highest due to hemoglobin synthesis. Loss of function mutations in SLC25A37 can result in profound anemia and are embryonically lethal in animal models, while altered expression or regulation of the protein is linked with several human diseases involving impaired erythropoiesis and mitochondrial dysfunction. Mitoferrin-1 forms oligomeric complexes with the ABCB10 transporter and ferrochelatase, enabling efficient delivery of iron for heme synthesis. Although both mitoferrin-1 and its paralog mitoferrin-2 (SLC25A28) contribute to mitochondrial iron import, mitoferrin-1 is essential when iron demand is high, as in erythroid cells, and its dysfunction cannot be fully compensated by mitoferrin-2[1][2][3]. There are currently no clinically approved drugs targeting mitoferrin-1, but its central role in iron metabolism makes it a candidate for therapeutic research in disorders of mitochondrial iron homeostasis.
Not applicable, as no approved drugs directly target Mitoferrin-1. Potential mechanisms would involve inhibition or modulation of mitochondrial iron import, but this remains experimental[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitoferrin-1 (SLC25A37).